Bio-Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

4:00pm EDT
Price Change (% chg)

$-0.51 (-0.42%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BIO.N


Bio-Rad Laboratories, Inc. (Bio-Rad), manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life... (more)


Beta: 1.22
Market Cap (Mil.): $3,472.03
Shares Outstanding (Mil.): 28.87
Dividend: --
Yield (%): --


  BIO.N Industry Sector
P/E (TTM): 57.36 32.92 33.58
EPS (TTM): 2.11 -- --
ROI: 2.03 10.13 17.30
ROE: 2.84 12.00 18.05
Search Stocks

CORRECTED-U.S. CDC recommends combo HIV test for faster detection of virus

(Corrects in paragraph 3 to show company making recommended test is Bio-Rad Laboratories, not Alere Inc)

27 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks